The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 1, 2013, Pages 71-75

  Azzam, Hanan A G ^a   Abousamra, Nashwa K ^a   Goda, Hossam ^a   El Shouky, Reda ^a   El Gilany, Abdel Hady ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

CD40L; HELLP; normal pregnancy; preeclampsia; sCD40L

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD40 LIGAND; CREATININE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELLP SYNDROME; HUMAN; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ADULT; BLOOD PLATELETS; CD40 LIGAND; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELLP SYNDROME; HUMANS; INFLAMMATION; PLATELET ACTIVATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROSPECTIVE STUDIES; SERUM ALBUMIN; SOLUBILITY; THROMBOPHILIA; YOUNG ADULT;

EID: 84871818491     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835a8aca     Document Type: Article

References (26)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
2. Martin L, Pernol RC. Current Obstetric and Gynecologic Diagnosis and Treatment, 6th ed. Norwalk CT: Appleton & Lange; 1987.
3. Jiang YH, Wang YQ, Wang J, YE RH. A case of aggravation of hemolytic anemia, elevated liver enzymes and low platelet count syndrome after delivery. Chin Med J 2011; 124:1261-1263.
4. Ertan AK, Wagner S, Hendrik HJ, Tanriverdi HA, Schmidt W. Clinical and biophysical aspects of HELLP-syndrome. J Perinat Med 2002; 30:483-489. (Pubitemid 36014762)
5. Rahman TM, Wendon J. Severe hepatic dysfunction in pregnancy. QJM 2002; 95:343-357. (Pubitemid 34649670)
6. Janes SL, Kyle PM, Redman C, Goodall AH. Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia. Thromb Haemost 1995; 74:1059-1063.
7. Holthe MR, Staff AC, Berge LN, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004; 190:1128-1134. (Pubitemid 38561536)
8. Konijnenberg A, van der Post JA, Mol BW, Schaap MC, Lazarov R, Bleker OP, et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. AmJ Obstet Gynecol 1997; 177:434-442. (Pubitemid 27385727)
9. Von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100:27-40. (Pubitemid 46066771)
10. Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res 2003; 92:944-946. (Pubitemid 36588490)
11. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Fö rster R, Mü ller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391:591-594. (Pubitemid 28157601)
12. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001; 58:4-43. (Pubitemid 32143961)
13. Lee Y, Lee WH, Lee SC, Ahn KJ, Choi YH, Park SW, et al. CD40L activation in circulating platelets in patient with acute coronary syndrome. Cardiology 1999; 92:11-16. (Pubitemid 30055077)
14. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD 154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98:1047-1054.
15. Mach F, Schonbeck U, Bonnefoy IY, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997; 96:396-399. (Pubitemid 27329409)
16. Urbich C, Mallat Z, Tedgui A, Clauss M, Zeiher AM, Dimmeler S. Upregulation of TRAF-3 byshear stress blocks CD40 mediated endothelial activation. J Clin Invest 2001; 108:1451-1458. (Pubitemid 33091982)
17. Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by preeclampsia with and without intrauterine growth retardation. Gynecol Obstet Invest 2007; 64:8-13. (Pubitemid 47014373)
18. Alacacioglu I, Ozcan MA, Piskin O, Yuksel F, Alacacioglu A, Demirkan F, et al. Increased concentration of soluble CD40 ligand in preeclampsia. Clin Appl Thromb Hemost 2007; 13:201-205. (Pubitemid 46548376)
19. Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006; 107:896-900.
20. Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004; 70:2317-2324. (Pubitemid 39657180)
21. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204. (Pubitemid 20007682)
22. Bar J, Ben-haroush A, Lahav J, Sullivan M. Interaction between platelets and cytokines-a possible role in the pathogenesis of preeclampsia. Vasc Dis Prev 2004; 1:101-107.
23. Lukanov TH, Bojinova SI, Emin AL, Veleva GL, Popova VS, Konova EI. Upregulation of the CD40-CD40 ligand system in preeclampsia. Int J Gynaecol Obstet 2009; 105:257-260.
24. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106:896-899. (Pubitemid 34925319)
25. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999; 5:1313-1316. (Pubitemid 29535611)
26. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92:1041-1048. (Pubitemid 36588504)